Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.

Alexander Egle* (First author), Thomas Melchardt (First author), Petra Obrtlíková, Lukáš Smolej, Tomáš Kozák, Michael Steurer, Johannes Andel, Sonja Burgstaller, Eva Mikušková, Liana Gercheva, Thomas Nösslinger, Tomáš Papajík, Miriam Ladická, Michael Girschikofsky, Mikuláš Hrubiško, Ulrich Jäger, Daniela Voskova, Martin Pecherstorfer, Eva Králiková, Christina BurcoveanuEmil Spasov, Andreas Petzer, Georgi Mihaylov, Julian Raynov, Horst Oexle, August Zabernigg, Emília Flochová, Stanislav Palášthy, Olga Stehlíková, Michael Doubek, Petra Altenhofer, Lukas Weiss (Co-author), Teresa Magnes (Co-author), Lisa Pleyer (Co-author), Anton Klingler, Jiří Mayer, Richard Greil (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1405
JournalCANCER MEDICINE
Volume8
Issue number4
DOIs
Publication statusPublished - 2019

Keywords

  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • LYMPHOMA

Cite this